Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PDE9-IN-(S)-C33 ((S)-C33) is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 55.00 | |
5 mg | In stock | $ 112.00 | |
10 mg | In stock | $ 159.00 | |
25 mg | In stock | $ 259.00 | |
50 mg | In stock | $ 383.00 | |
100 mg | In stock | $ 571.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 126.00 |
Description | PDE9-IN-(S)-C33 ((S)-C33) is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research. |
Synonyms | (S)-C33 |
Molecular Weight | 357.84 |
Formula | C18H20ClN5O |
CAS No. | 2066488-39-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (265.48 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PDE9-IN-(S)-C33 2066488-39-7 Metabolism PDE PDE9 IN (S) C33 Phosphodiesterase (PDE) Inhibitor inhibit PDE9-IN-C33 PDE9IN(S)C33 (S)-C33 Central nervous system diseases Selectivity Diabetes C 33 C-33 C33 inhibitor